Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in TOVX — Theriva Biologics, Inc.

CIK 1214717 BOSTON, MA
Back to TOVX Full portfolio

Position in TOVX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$73,504
-$16,547 QoQ
Shares Held
294,021
-34.7% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 24 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TOVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. TOVX ranks #459 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in TOVX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $73,504 294,021
2026-03-31 $90,051 450,263
2025-12-31 $44,537 212,087
2025-09-30 $11,565 28,209
2025-06-30 $7,997 18,601
2025-03-31 $20,550 18,683
2024-06-30 $33,879 141,168
2024-03-31 $66,348 141,168
2023-12-31 $60,702 141,168
2023-09-30 $76,230 141,168
2023-06-30 $116,301 116,301
2023-03-31 $81,410 116,301
2022-12-31 $52,335 116,301
2022-09-30 $115,415 116,581